{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T13:48:25Z","timestamp":1771595305186,"version":"3.50.1"},"reference-count":78,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T00:00:00Z","timestamp":1726185600000},"content-version":"am","delay-in-days":348,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.euroneuro.2023.06.005","type":"journal-article","created":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T07:25:16Z","timestamp":1686900316000},"page":"93-104","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Antipsychotic use and 28-day mortality in patients hospitalized with COVID-19: A multicenter observational retrospective study"],"prefix":"10.1016","volume":"75","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1121-8641","authenticated-orcid":false,"given":"Marina","family":"S\u00e1nchez-Rico","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandro","family":"Ed\u00e1n-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Olfson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jes\u00fas M.","family":"Alvarado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillaume","family":"Airagnes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katayoun","family":"Rezaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aude","family":"Delcuze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hugo","family":"Peyre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0976-1514","authenticated-orcid":false,"given":"Fr\u00e9d\u00e9ric","family":"Limosin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Hoertel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2023.06.005_bib0001","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1080\/03610910902859574","article-title":"Using the Standardized Difference to Compare the Prevalence of a Binary Variable Between Two Groups in Observational Research","volume":"38","author":"Austin","year":"2009","journal-title":"Communications in Statistics - Simulation and Computation"},{"key":"10.1016\/j.euroneuro.2023.06.005_bib0002","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.3390\/pharmaceutics13091400","article-title":"Combination Therapy with Fluoxetine and the Nucleoside Analog GS-441524 Exerts Synergistic Antiviral Effects against Different SARS-CoV-2 Variants In Vitro","volume":"13","author":"Brunotte","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.euroneuro.2023.06.005_bib0003","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1111\/bcp.15126","article-title":"Safety and efficacy of fluvoxamine in COVID-19 ICU patients: An open label, prospective cohort trial with matched controls","volume":"88","author":"Calusic","year":"2022","journal-title":"Brit J Clinical Pharma"},{"key":"10.1016\/j.euroneuro.2023.06.005_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.xcrm.2020.100142","article-title":"Pharmacological Inhibition of Acid Sphingomyelinase Prevents Uptake of SARS-CoV-2 by Epithelial Cells","volume":"1","author":"Carpinteiro","year":"2020","journal-title":"Cell Reports Medicine"},{"key":"10.1016\/j.euroneuro.2023.06.005_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100701","article-title":"Inhibition of acid sphingomyelinase by ambroxol prevents SARS-CoV-2 entry into epithelial cells","volume":"296","author":"Carpinteiro","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.euroneuro.2023.06.005_bib0006","doi-asserted-by":"crossref","unstructured":"Chevance, A., Gourion, D., Hoertel, N., Llorca, P.-M., Thomas, P., Bocher, R., Moro, M.-R., Lapr\u00e9vote, V., Benyamina, A., Fossati, P., Masson, M., Leaune, E., Leboyer, M., Gaillard, R., 2020. Assurer les soins aux patients souffrant de troubles psychiques en France pendant l\u2019\u00e9pid\u00e9mie \u00e0 SARS-CoV-2. L'Enc\u00e9phale 46, S3\u2013S13. doi:10.1016\/j.encep.2020.03.001.","DOI":"10.1016\/j.encep.2020.03.001"},{"key":"10.1016\/j.euroneuro.2023.06.005_bib0007","doi-asserted-by":"crossref","unstructured":"Clelland, C.L., Ramiah, K., Steinberg, L., Clelland, J.D., 2022. Analysis of the impact of antidepressants and other medications on COVID-19 infection risk in a chronic psychiatric in-patient cohort. BJPsych open 8, e6. doi:10.1192\/bjo.2021.1053.","DOI":"10.1192\/bjo.2021.1053"},{"key":"10.1016\/j.euroneuro.2023.06.005_bib0008","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.molmed.2010.10.010","article-title":"Antipsychotic drugs and obesity","volume":"17","author":"Correll","year":"2011","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.euroneuro.2023.06.005_bib0009","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3390\/microorganisms9020339","article-title":"Fluoxetine Can Inhibit SARS-CoV-2","volume":"9","author":"Dechaumes","year":"2021","journal-title":"In Vitro. Microorganisms"},{"key":"10.1016\/j.euroneuro.2023.06.005_bib0010","doi-asserted-by":"crossref","first-page":"21633","DOI":"10.1038\/s41598-021-00755-z","article-title":"Link between serum lipid signature and prognostic factors in COVID-19 patients","volume":"11","author":"Dei Cas","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.euroneuro.2023.06.005_bib0011","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1007\/s40265-021-01636-5","article-title":"Fluvoxamine for the Early Treatment of SARS-CoV-2 Infection: A Review of Current Evidence","volume":"81","author":"Facente","year":"2021","journal-title":"Drugs"},{"key":"10.1016\/j.euroneuro.2023.06.005_bib0012","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.euroneuro.2022.10.004","article-title":"Psychotropic drug repurposing for COVID-19: A Systematic Review and Meta-Analysis","volume":"66","author":"Fico","year":"2023","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2023.06.005_bib0013","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1001\/jamapsychiatry.2021.2274","article-title":"Association Between Mental Health Disorders and Mortality Among Patients With COVID-19 in 7 Countries: A Systematic Review and Meta-analysis","volume":"78","author":"Fond","year":"2021","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.euroneuro.2023.06.005_bib0014","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1093\/schbul\/sbaa158","article-title":"Disparities in Intensive Care Unit Admission and Mortality Among Patients With Schizophrenia and COVID-19: A National Cohort Study","volume":"47","author":"Fond","year":"2021","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.euroneuro.2023.06.005_bib0015","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.encep.2020.07.003","article-title":"Increased in-hospital mortality from COVID-19 in patients with schizophrenia","volume":"47","author":"Fond","year":"2021","journal-title":"L'Enc\u00e9phale"},{"key":"10.1016\/j.euroneuro.2023.06.005_bib0016","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.755600","article-title":"Antidepressant and Antipsychotic Drugs Reduce Viral Infection by SARS-CoV-2 and Fluoxetine Shows Antiviral Activity Against the Novel Variants in vitro","volume":"12","author":"Fred","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.euroneuro.2023.06.005_bib0017","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s41398-022-02109-3","article-title":"Association between antidepressant use and ED or hospital visits in outpatients with SARS-CoV-2","volume":"12","author":"Fritz","year":"2022","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.euroneuro.2023.06.005_bib0018","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1192\/bjp.2020.151","article-title":"Clozapine treatment and risk of COVID-19 infection: retrospective cohort study","volume":"219","author":"Govind","year":"2021","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2023.06.005_bib0019","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1198\/106186006X137047","article-title":"Optimal Full Matching and Related Designs via Network Flows","volume":"15","author":"Hansen","year":"2006","journal-title":"J. Comput. Graph. Statist."},{"key":"10.1016\/j.euroneuro.2023.06.005_bib0020","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1038\/s41380-021-01432-3","article-title":"Mechanisms of action of fluvoxamine for COVID-19: a historical review","volume":"27","author":"Hashimoto","year":"2022","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2023.06.005_bib0021","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/SLA.0000000000001648","article-title":"Acid Sphingomyelinase Inhibition in Stored Erythrocytes Reduces Transfusion-Associated Lung Inflammation","volume":"265","author":"Hoehn","year":"2017","journal-title":"Ann. Surg."},{"key":"10.1016\/j.euroneuro.2023.06.005_bib0022","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.36510","article-title":"Do the Selective Serotonin Reuptake Inhibitor Antidepressants Fluoxetine and Fluvoxamine Reduce Mortality Among Patients With COVID-19?","volume":"4","author":"Hoertel","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.euroneuro.2023.06.005_bib0023","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1038\/s41591-020-1001-6","article-title":"A stochastic agent-based model of the SARS-CoV-2 epidemic in France","volume":"26","author":"Hoertel","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.euroneuro.2023.06.005_bib0024","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/taab016","article-title":"Impact of the timing and adherence to face mask use on the course of the COVID-19 epidemic in France","volume":"28","author":"Hoertel","year":"2021","journal-title":"J. Travel Med."},{"key":"10.1016\/j.euroneuro.2023.06.005_bib0025","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jad.2012.09.023","article-title":"Are subjects in treatment trials of panic disorder representative of patients in routine clinical practice? Results from a national sample","volume":"146","author":"Hoertel","year":"2013","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.euroneuro.2023.06.005_bib0026","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1080\/13607863.2019.1691146","article-title":"Generalizability of pharmacologic and psychotherapy trial results for late-life unipolar depression","volume":"25","author":"Hoertel","year":"2021","journal-title":"Aging Ment. Health"},{"key":"10.1016\/j.euroneuro.2023.06.005_bib0027","doi-asserted-by":"crossref","first-page":"7098","DOI":"10.1038\/s41380-021-01254-3","article-title":"Repurposing antidepressants inhibiting the sphingomyelinase acid\/ceramide system against COVID-19: current evidence and potential mechanisms","volume":"26","author":"Hoertel","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2023.06.005_bib0028","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.bpsgos.2021.12.007","article-title":"Risk of Death in Individuals Hospitalized for COVID-19 With and Without Psychiatric Disorders: An Observational Multicenter Study in France","volume":"3","author":"Hoertel","year":"2023","journal-title":"Biological Psychiatry Global Open Science"},{"key":"10.1016\/j.euroneuro.2023.06.005_bib0029","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1002\/cpt.2317","article-title":"Association Between FIASMAs and Reduced Risk of Intubation or Death in Individuals Hospitalized for Severe COVID-19: An Observational Multicenter Study","volume":"110","author":"Hoertel","year":"2021","journal-title":"Clin Pharma and Therapeutics"},{"key":"10.1016\/j.euroneuro.2023.06.005_bib0030","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1017\/S2045796021000743","article-title":"Association between benzodiazepine receptor agonist use and mortality in patients hospitalised for COVID-19: a multicentre observational study","volume":"31","author":"Hoertel","year":"2022","journal-title":"Epidemiol Psychiatr Sci"},{"key":"10.1016\/j.euroneuro.2023.06.005_bib0032","doi-asserted-by":"crossref","first-page":"5199","DOI":"10.1038\/s41380-021-01021-4","article-title":"Association between antidepressant use and reduced risk of intubation or death in hospitalized patients with COVID-19: results from an observational study","volume":"26","author":"Hoertel","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2023.06.005_bib0033","doi-asserted-by":"crossref","first-page":"3766","DOI":"10.1111\/bcp.14784","article-title":"Dexamethasone use and mortality in hospitalized patients with coronavirus disease 2019: A multicentre retrospective observational study","volume":"87","author":"Hoertel","year":"2021","journal-title":"Brit Jnl Clinical Pharma"},{"key":"10.1016\/j.euroneuro.2023.06.005_bib0034","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s40261-021-01001-0","article-title":"Observational Study of Chlorpromazine in Hospitalized Patients with COVID-19","volume":"41","author":"Hoertel","year":"2021","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.euroneuro.2023.06.005_bib0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0247122","article-title":"Observational study of haloperidol in hospitalized patients with COVID-19","volume":"16","author":"Hoertel","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.euroneuro.2023.06.005_bib0036","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/s41398-022-01804-5","article-title":"Association between FIASMA psychotropic medications and reduced risk of intubation or death in individuals with psychiatric disorders hospitalized for severe COVID-19: an observational multicenter study","volume":"12","author":"Hoertel, S\u00e1nchez-Rico","year":"2022","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.euroneuro.2023.06.005_bib0037","doi-asserted-by":"crossref","first-page":"5882","DOI":"10.3390\/jcm11195882","article-title":"Antidepressant Use and Its Association with 28-Day Mortality in Inpatients with SARS-CoV-2: Support for the FIASMA Model against COVID-19","volume":"11","author":"Hoertel","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.euroneuro.2023.06.005_bib0038","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.euroneuro.2023.03.001","article-title":"The elephant in the room: Medication as confounder","volume":"71","author":"Ilzarbe","year":"2023","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2023.06.005_bib0039","doi-asserted-by":"crossref","first-page":"20866","DOI":"10.1038\/s41598-021-00286-7","article-title":"Inferring a causal relationship between ceramide levels and COVID-19 respiratory distress","volume":"11","author":"Khodadoust","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.euroneuro.2023.06.005_bib0040","first-page":"1","article-title":"Association of fluvoxamine with mortality and symptom resolution among inpatients with COVID-19 in Uganda: a prospective interventional open-label cohort study","author":"Kirenga","year":"2023","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2023.06.005_bib0041","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/s41380-021-01309-5","article-title":"The acid sphingomyelinase\/ceramide system in COVID-19","volume":"27","author":"Kornhuber","year":"2022","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2023.06.005_bib0042","doi-asserted-by":"crossref","first-page":"e23852","DOI":"10.1371\/journal.pone.0023852","article-title":"Identification of Novel Functional Inhibitors of Acid Sphingomyelinase","volume":"6","author":"Kornhuber","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.euroneuro.2023.06.005_bib0043","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1004202","article-title":"Association of severe mental illness and septic shock case fatality rate in patients admitted to the intensive care unit: A national population-based cohort study","volume":"20","author":"Lakbar","year":"2023","journal-title":"PLoS Med."},{"key":"10.1016\/j.euroneuro.2023.06.005_bib0044","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1111\/j.1360-0443.2011.03547.x","article-title":"CORRELATION IS NO CAUSATION: GYMNASIUM PROLIFERATION AND THE RISK OF OBESITY: Letters to the Editor","volume":"106","author":"Le Strat","year":"2011","journal-title":"Addiction"},{"key":"10.1016\/j.euroneuro.2023.06.005_bib0045","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1001\/jama.2020.22760","article-title":"Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19: A Randomized Clinical Trial","volume":"324","author":"Lenze","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.euroneuro.2023.06.005_bib0046","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1093\/schbul\/sbv037","article-title":"Dose Equivalents for Second-Generation Antipsychotic Drugs: The Classical Mean Dose Method","volume":"41","author":"Leucht","year":"2015","journal-title":"SCHBUL"},{"key":"10.1016\/j.euroneuro.2023.06.005_bib0047","doi-asserted-by":"crossref","first-page":"4794","DOI":"10.3390\/ijms22094794","article-title":"Metabolic Signatures Associated with Severity in Hospitalized COVID-19 Patients","volume":"22","author":"Mar\u00edn-Corral","year":"2021","journal-title":"IJMS"},{"key":"10.1016\/j.euroneuro.2023.06.005_bib0048","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/S2215-0366(21)00301-1","article-title":"COVID-19 vaccine uptake in patients with psychiatric disorders admitted to or residing in a university psychiatric hospital","volume":"8","author":"Mazereel","year":"2021","journal-title":"The Lancet Psychiatry"},{"key":"10.1016\/j.euroneuro.2023.06.005_bib0049","doi-asserted-by":"crossref","unstructured":"M\u00fchle, C., Kremer, A., Vetter, M., Schmid, J., Achenbach, S., Schumacher, F., Lenz, B., Cougoule, C., Hoertel, N., Carpinteiro, A., Gulbins, E., Kleuser, B., Kornhuber, J., 2022. COVID-19 and its clinical severity are associated with alterations of plasma sphingolipids and enzyme activities of sphingomyelinase and ceramidase (preprint). Infectious Diseases (except HIV\/AIDS). https:\/\/doi.org\/10.1101\/2022.01.19.22269391","DOI":"10.1101\/2022.01.19.22269391"},{"key":"10.1016\/j.euroneuro.2023.06.005_bib0050","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1001\/jamapsychiatry.2021.2503","article-title":"Association Between Antipsychotic Use and COVID-19 Mortality Among People With Serious Mental Illness","volume":"78","author":"Nemani","year":"2021","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.euroneuro.2023.06.005_bib0051","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.10743","article-title":"Association Between the Use of Psychotropic Medications and the Risk of COVID-19 Infection Among Long-term Inpatients With Serious Mental Illness in a New York State\u2013wide Psychiatric Hospital System","volume":"5","author":"Nemani","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.euroneuro.2023.06.005_bib0052","doi-asserted-by":"crossref","first-page":"389","DOI":"10.18071\/isz.74.0389","article-title":"Fluoxetine use is associated with improved survival of patients with COVID-19 pneumonia\u00a0: A retrospective case-control study","volume":"74","author":"N\u00e9meth","year":"2021","journal-title":"Ideggyogy Sz"},{"key":"10.1016\/j.euroneuro.2023.06.005_bib0053","doi-asserted-by":"crossref","first-page":"e20773","DOI":"10.2196\/20773","article-title":"Natural Language Processing for Rapid Response to Emergent Diseases: Case Study of Calcium Channel Blockers and Hypertension in the COVID-19 Pandemic","volume":"22","author":"Neuraz","year":"2020","journal-title":"J. Med. Internet Res."},{"key":"10.1016\/j.euroneuro.2023.06.005_bib0054","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.33090","article-title":"Mortality Risk Among Patients With COVID-19 Prescribed Selective Serotonin Reuptake Inhibitor Antidepressants","volume":"4","author":"Oskotsky","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.euroneuro.2023.06.005_bib0055","doi-asserted-by":"crossref","first-page":"13623","DOI":"10.3390\/ijms232113623","article-title":"Antiviral and Anti-Inflammatory Activities of Fluoxetine in a SARS-CoV-2 Infection Mouse Model","volume":"23","author":"P\u00e9ricat","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.euroneuro.2023.06.005_bib0056","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1054644","article-title":"Impact of fluvoxamine on outpatient treatment of COVID-19 in Honduras in a prospective observational real-world study","volume":"13","author":"Pineda","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.euroneuro.2023.06.005_bib0057","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.620044","article-title":"Obesity and Mortality Among Patients Diagnosed With COVID-19: A Systematic Review and Meta-Analysis","volume":"8","author":"Poly","year":"2021","journal-title":"Front. Med."},{"key":"10.1016\/j.euroneuro.2023.06.005_bib0058","doi-asserted-by":"crossref","DOI":"10.1016\/j.archger.2021.104388","article-title":"Delirium and Mortality in Coronavirus Disease 2019 (COVID-19) \u2013 A Systematic Review and Meta-analysis","volume":"95","author":"Pranata","year":"2021","journal-title":"Arch. Gerontol. Geriatr."},{"key":"10.1016\/j.euroneuro.2023.06.005_bib0059","doi-asserted-by":"crossref","first-page":"667","DOI":"10.7326\/M22-3305","article-title":"Oral Fluvoxamine With Inhaled Budesonide for Treatment of Early-Onset COVID-19: A Randomized Platform Trial","volume":"176","author":"Reis","year":"2023","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.euroneuro.2023.06.005_bib0060","doi-asserted-by":"crossref","first-page":"e42","DOI":"10.1016\/S2214-109X(21)00448-4","article-title":"Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, platform clinical trial","volume":"10","author":"Reis","year":"2022","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.euroneuro.2023.06.005_bib0061","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.schres.2017.07.033","article-title":"Dose equivalents for second generation long-acting injectable antipsychotics: The minimum effective dose method","volume":"193","author":"Rothe","year":"2018","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2023.06.005_bib0062","doi-asserted-by":"crossref","first-page":"3494","DOI":"10.1038\/s41598-018-21348-3","article-title":"Citalopram inhibits platelet function independently of SERT-mediated 5-HT transport","volume":"8","author":"Roweth","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.euroneuro.2023.06.005_bib0063","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/taab195","article-title":"Melatonin does not reduce mortality in adult hospitalized patients with COVID-19: a multicenter retrospective observational study","volume":"29","author":"S\u00e1nchez-Rico","year":"2022","journal-title":"J. Travel Med."},{"key":"10.1016\/j.euroneuro.2023.06.005_bib0064","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1176\/appi.ajp.2021.21020196","article-title":"Is a Diagnosis of Schizophrenia Spectrum Disorder Associated With Increased Mortality in Patients With COVID-19?","volume":"179","author":"S\u00e1nchez-Rico","year":"2022","journal-title":"AJP"},{"key":"10.1016\/j.euroneuro.2023.06.005_bib0065","doi-asserted-by":"crossref","first-page":"5891","DOI":"10.3390\/jcm10245891","article-title":"Hydroxyzine Use and Mortality in Patients Hospitalized for COVID-19: A Multicenter Observational Study","volume":"10","author":"S\u00e1nchez-Rico","year":"2021","journal-title":"JCM"},{"key":"10.1016\/j.euroneuro.2023.06.005_bib0066","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/j.gerinurse.2021.03.007","article-title":"Dementia as a mortality predictor among older adults with COVID-19: A systematic review and meta-analysis of observational study","volume":"42","author":"Saragih","year":"2021","journal-title":"Geriatr. Nurs. (Minneap)"},{"key":"10.1016\/j.euroneuro.2023.06.005_bib0067","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1080\/22221751.2020.1829082","article-title":"Targeting the endolysosomal host-SARS-CoV-2 interface by clinically licensed functional inhibitors of acid sphingomyelinase (FIASMA) including the antidepressant fluoxetine","volume":"9","author":"Schloer","year":"2020","journal-title":"Emerging Microbes & Infections"},{"key":"10.1016\/j.euroneuro.2023.06.005_bib0068","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1111\/bph.15418","article-title":"Drug synergy of combinatory treatment with remdesivir and the repurposed drugs fluoxetine and itraconazole effectively impairs SARS-CoV-2 infection in vitro","volume":"178","author":"Schloer","year":"2021","journal-title":"British J Pharmacology"},{"key":"10.1016\/j.euroneuro.2023.06.005_bib0069","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofab050","article-title":"Prospective Cohort of Fluvoxamine for Early Treatment of Coronavirus Disease 19","volume":"8","author":"Seftel","year":"2021","journal-title":"Open Forum Infectious Diseases"},{"key":"10.1016\/j.euroneuro.2023.06.005_bib0070","doi-asserted-by":"crossref","first-page":"7093","DOI":"10.1038\/s41380-021-01222-x","article-title":"Diversity of mechanism of action of psychotropic drugs in their anti-COVID-19 properties","volume":"26","author":"Stip","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2023.06.005_bib0071","doi-asserted-by":"crossref","DOI":"10.1016\/j.jclinepi.2013.01.013","article-title":"Prognostic score\u2013based balance measures can be a useful diagnostic for propensity score methods in comparative effectiveness research","volume":"66","author":"Stuart","year":"2013","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.euroneuro.2023.06.005_bib0072","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.652688","article-title":"Fluvoxamine: A Review of Its Mechanism of Action and Its Role in COVID-19","volume":"12","author":"Sukhatme","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.euroneuro.2023.06.005_bib0073","doi-asserted-by":"crossref","first-page":"10198","DOI":"10.3390\/ijms221910198","article-title":"Severity of COVID-19 Patients Predicted by Serum Sphingolipids Signature","volume":"22","author":"Torretta","year":"2021","journal-title":"IJMS"},{"key":"10.1016\/j.euroneuro.2023.06.005_bib0074","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S2215-0366(21)00232-7","article-title":"Mental disorders and risk of COVID-19-related mortality, hospitalisation, and intensive care unit admission: a systematic review and meta-analysis","volume":"8","author":"Vai","year":"2021","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.euroneuro.2023.06.005_bib0075","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1097\/MLR.0b013e31819432e5","article-title":"A Modification of the Elixhauser Comorbidity Measures Into a Point System for Hospital Death Using Administrative Data","volume":"47","author":"Van Walraven","year":"2009","journal-title":"Med. Care"},{"key":"10.1016\/j.euroneuro.2023.06.005_bib0076","doi-asserted-by":"crossref","first-page":"573","DOI":"10.7326\/0003-4819-147-8-200710160-00010","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies","volume":"147","author":"Von Elm","year":"2007","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.euroneuro.2023.06.005_bib0077","doi-asserted-by":"crossref","first-page":"16","DOI":"10.21037\/atm.2018.12.10","article-title":"Balance diagnostics after propensity score matching","volume":"7","author":"Zhang","year":"2019","journal-title":"Ann. Transl. Med"},{"key":"10.1016\/j.euroneuro.2023.06.005_bib0078","doi-asserted-by":"crossref","first-page":"5890","DOI":"10.1038\/s41598-021-85049-0","article-title":"The serotonin reuptake inhibitor Fluoxetine inhibits SARS-CoV-2 in human lung tissue","volume":"11","author":"Zimniak","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.euroneuro.2023.06.005_fur1","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1038\/s41380-021-01393-7","volume":"27","author":"Hoertel","year":"2022","journal-title":"Mol. Psychiatry"}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X23001244?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X23001244?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T18:07:09Z","timestamp":1760378829000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X23001244"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":78,"alternative-id":["S0924977X23001244"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2023.06.005","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antipsychotic use and 28-day mortality in patients hospitalized with COVID-19: A multicenter observational retrospective study","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2023.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. and ECNP. All rights reserved.","name":"copyright","label":"Copyright"}]}}